Cogent Biosciences, Inc. (COGT)
35.10
-0.77
(-2.15%)
USD |
NASDAQ |
May 07, 09:52
Cogent Biosciences SG&A Expense (TTM) : 51.68M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Syndax Pharmaceuticals, Inc. | 176.24M |
| Vera Therapeutics, Inc. | 100.22M |
| Terns Pharmaceuticals, Inc. | 32.24M |
| Nuvalent, Inc. | 107.34M |
| Insmed, Inc. | 701.17M |